Lower Cholesterol: Pharmacist Tips & Strategies
- Pharmacists can substantially impact hyperlipidemia management through personalized strategies,according to Amanda Gronniger,PharmD,a pharmacy clinical ambulatory specialist at Baptist Health South Florida. Gronniger emphasized the importance of tailoring lifestyle...
- In an interview, Gronniger highlighted the collaborative role pharmacists play in optimizing lipid-lowering therapy, especially for high-risk patients with diabetes or chronic kidney disease (CKD).
- Gronniger noted that while lifestyle modifications are essential, some patients require medication.She pointed out that lifestyle changes alone might only decrease LDL cholesterol by 5% to 15%.
Lower your cholesterol effectively wiht pharmacist-led strategies designed for lasting results. Amanda gronniger, PharmD, reveals how personalized lifestyle counseling and tailored lipid-lowering therapy can significantly impact your health. Pharmacists play a key role in optimizing cholesterol management, especially for those at high risk, offering solutions to improve medication adherence and address side effects. learn about emerging therapies, including oral PCSK9 inhibitors, that promise to revolutionize how we manage LDL and lipoprotein(a) levels. News Directory 3 provides insights into patient education and how pharmacists can adjust medications or dosages to suit individual needs. Discover what’s next in hyperlipidemia management.
Pharmacist-Led Strategies for Hyperlipidemia Management
Updated June 03,2025
Pharmacists can substantially impact hyperlipidemia management through personalized strategies,according to Amanda Gronniger,PharmD,a pharmacy clinical ambulatory specialist at Baptist Health South Florida. Gronniger emphasized the importance of tailoring lifestyle counseling to individual patient needs, focusing on achievable diet and exercise modifications.
In an interview, Gronniger highlighted the collaborative role pharmacists play in optimizing lipid-lowering therapy, especially for high-risk patients with diabetes or chronic kidney disease (CKD). She also addressed common challenges in statin adherence, offering solutions to overcome patient hesitancy through education and individualized treatment adjustments.
Gronniger noted that while lifestyle modifications are essential, some patients require medication.She pointed out that lifestyle changes alone might only decrease LDL cholesterol by 5% to 15%. For high-risk individuals or those with very high LDL levels, medications proven to reduce major adverse cardiovascular events (MACE) are often necessary.
Pharmacists can optimize cholesterol management by educating patients, coordinating prior authorizations, and managing adverse reactions, Gronniger said. With collaborative practice agreements, pharmacists can adjust lipid-lowering therapies, modify doses, or select choice medications when needed.
For patients with diabetes or CKD, Gronniger stressed the need for increased education regarding medications. She noted that guidelines recommend moderate-intensity statins for all diabetic patients aged 40 to 75, irrespective of ASCVD risk. Renal dose adjustments are also crucial for CKD patients, and pharmacists can recommend appropriate statins or dosages.
All patients should try to implement a healthy lifestyle for overall heart health… Just like with exercise, there is not a one-size-fits-all approach to diet—patients should focus on finding a dietary pattern that thay can realistically maintain over time.
Addressing statin adherence involves educating patients about the benefits and managing concerns about side effects. Gronniger suggested trying different statins or lowering the dose to improve tolerance. Providing reassurance and alternative treatment options can also significantly improve adherence.
What’s next
Gronniger is enthusiastic about emerging therapies like lipoprotein(a) [Lp(a)] lowering therapies, oral PCSK9 inhibitors, and gene editing therapy, which show promise in significantly reducing LDL and Lp(a) levels, possibly revolutionizing cholesterol management.